Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 5 completed trials

    Completion Rate
    100%(5/5)
    Active Trials
    1(17%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Not Applicable
    6
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution6 total trials
    N/ANon-phased studies
    6(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    5 of 5 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    6

    all time

    Status Distribution
    Active(1)
    Completed(5)

    Detailed Status

    Completed5
    Active, not recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    6
    Active
    1
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A6 (100.0%)

    Trials by Status

    active_not_recruiting117%
    completed583%

    Recent Activity

    1 active trials
    Showing 5 of 6
    completednot_applicable

    Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis

    NCT06165354
    completednot_applicable

    Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children

    NCT06148194
    active_not_recruitingnot_applicable

    Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections

    NCT05929599
    completednot_applicable

    Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases

    NCT05783856
    completednot_applicable

    Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children

    NCT05378022
    View all 6 trials

    Clinical Trials (6)

    Showing 6 of 6 trials
    NCT06165354Not Applicable

    Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis

    Completed
    NCT06148194Not Applicable

    Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children

    Completed
    NCT05929599Not Applicable

    Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections

    Active Not Recruiting
    NCT05783856Not Applicable

    Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases

    Completed
    NCT05378022Not Applicable

    Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children

    Completed
    NCT05164692Not Applicable

    Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children

    Completed

    All 6 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    6